Stockchase Opinions

Jim Cramer - Mad Money PerkinElmer PKI-N WATCH Aug 08, 2022

He recommends it, but has had a rough year. It did good business during Covid, mostly in Covid testing. But this created tough comparisons. Last Tuesday, they reported a modest revenue beat and stronger earnings beat, plus gave encouraging full-year guidance. They're restructuring. See what they say after earnings on Thursday.
$154.090

Stock price when the opinion was issued

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.